ARA-290 / Cibinetide
ARA-290 / CibinetideCreate a free account, then upgrade to Premium or Lifetime to unlock the full research article, mechanism of action, results timeline, dosing protocol, and dose calculator for ARA-290 / Cibinetide.
Activates the innate repair receptor (IRR) to mediate cytoprotection
Non-erythropoietic—does not increase red blood cell mass or hematocrit
Modulates inflammation and can reduce pro-inflammatory cytokine release
May reduce neuropathic pain symptoms observed in clinical studies
Promotes small-fiber nerve repair and regeneration in preclinical and clinical work
Improves corneal nerve fiber density on clinical imaging assessments
Protects tissues from ischemia-reperfusion injury in animal models
May improve sensory function and nerve conduction measures in neuropathy
Can produce relatively rapid symptomatic effects in short-term studies
This peptide's combination-safety and interaction data below always stays visible, regardless of membership.
Important information. The data compiled from scientific literature is provided for educational purposes. Dosage ranges reflect what is reported in studies and do not constitute a recommendation, prescription, or usage guidance. Health decisions should always be made with a qualified professional.
Discussions
Community discussions are coming soon.